A: Human Microbiome and Public Health Targets
Our Active Working Groups
WMP members participate through Working Groups tasked with specific objectives, reporting their progress to the Executive Committee and the broader membership.
G: One Health Microbiome Partnerships

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
F: Environmental Microbiomes and Climate Change

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
E: FAIR Microbiome Data

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
A: Human Microbiome and Public Health Targets

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
B: Microbiome Technologies

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
C: Microbiome Product Development and Regulatory Science

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
D: Agrifood System Microbiomes

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
Microbiome Technologies
Establishing microbiome-based targets for public health interventions and policy development.

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
